Cencora Inc. (NYSE: COR) announced Eva C. Boratto will become Executive Vice President and Chief Financial Officer on June 29, 2026. Boratto will succeed James F. Cleary, who is retiring from the CFO role as previously announced.

Cleary will serve in an advisory capacity through the end of 2026 to facilitate the transition, according to the company statement.

Boratto most recently served as Chief Financial Officer of Bath & Body Works Inc., where she led the company's transformation strategy. During her tenure, the company implemented a cost savings program that delivered more than $300 million in cumulative savings.

Prior to Bath & Body Works, Boratto spent 12 years at CVS Health Corporation in various leadership roles, including Chief Financial Officer. She participated in developing the company's growth strategy and the integration of CVS's acquisition of Aetna.

Boratto currently serves on the boards of Mars Inc. and United Parcel Service Inc., chairing the audit committees at both companies. She holds an MBA from Drexel University and a Bachelor of Science in Accounting and Economics from Rutgers University.

Cencora reaffirmed its fiscal 2026 adjusted diluted earnings per share guidance range of $17.70 to $17.90. The company also maintained its long-term guidance for adjusted operating income growth of 7% to 10% and adjusted diluted EPS growth of 10% to 14%.

The pharmaceutical solutions company updated its fiscal 2026 EPS guidance in May from a previous range of $17.65 to $17.90 following share repurchases completed that month.